Tag: Cardiovascular Systems

everolimus

Cardiovascular Systems and Chansu Vascular Technologies partner to develop new everolimus DCBs

Cardiovascular Systems (CSI) has partnered with Chansu Vascular Technologies (CVT) to develop no...

TCT Connect 2020: Results demonstrate safety and procedural success of orbital atherectomy system

Cardiovascular Systems has announced the presentation of results from a large retrospective obse...
wirion

Cardiovascular Systems acquires Gardia Medical’s Wirion embolic protection system

Cardiovascular Systems recently announced that it has acquired the Wirion embolic protection sys...

First patients in the Middle East treated with Diamondback 360 Coronary Orbital Atherectomy System

  The first patients in the United Arab Emirates (UAE) have been treated with the Diamon...

First patients treated in United States with OrbusNeich Teleport Microcatheter

The first patients in the United States have been treated using the OrbusNeich Teleport Microcathete...

Sapphire II PRO becomes US’s first and only 1mm coronary balloon

Cardiovascular Systems has announced that the US FDA has granted 510(k) clearance for the OrbusN...

Cardiovascular Systems enrols first subject in ECLIPSE coronary clinical trial

Cardiovascular Systems and the Cardiovascular Research Foundation (CRF) have announced that the ...

Atherectomy is an important tool for optimising results of PCI in calcified lesions

Evan Shlofmitz (Northwell Health, Manhasset, USA) presented the results of the COAP-PCI (Clinica...

Martha Goldberg Aronson joins Cardiovascular Systems board of directors

Cardiovascular Systems (CSI) has announced the addition of independent board member Martha Goldberg ...

Cardiovascular Systems Micro Crown sustains high freedom from major adverse events at one year

Cardiovascular Systems (CSI) has released one-year results from its Coronary Orbital Atherectomy Sys...

Study demonstrates sustained benefit of endovascular intervention in patients with lower extremity peripheral artery disease

Cardiovascular systems (CSI) presented six-month data from its LIBERTY 360 degrees post-market s...